EUVIMEDEUVIMED entdecken
Crossref

Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS

Jinlong Yang, Chenyi Shi, Yipeng Cheng, Yuqi Zhu, Xinyi Yang, Yue Liang, Huitong Liang, Qinru Lin, Min Li, Jingna Xun, Jianping Liu, Chunhua Yin und 2 weitere

European Journal of Pharmaceutics and Biopharmaceutics · 2024

DOI: 10.1016/j.ejpb.2024.114353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Jinlong Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering and Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Institute of Genetics, …. Hauptthemen laut MEDLINE: HIV-1, Virus Latency, Emulsions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The latent reservoir of human immunodeficiency virus (HIV) is a major obstacle in the treatment of acquired immune deficiency syndrome (AIDS). The "shock and kill" strategy has emerged as a promising approach for clearing HIV latent reservoirs. However, current latency-reversing agents (LRAs) have limitations in effectively and safely activating the latent virus and reducing the HIV latent reservoirs in clinical practice. Previously, EK-16A was extracted from Euphorbia kansui, which had the effect of interfering with the HIV-1 latent reservoir and inhibiting HIV-1 entry. Nevertheless, there is no suitable and efficient EK-16A oral formulation for in vivo delivery and clinical use. In this study, an oral EK-16A self-nanoemulsifying drug delivery system (EK-16A-SNEDDS) was proposed to "shock" the HIV-1 latent reservoir. This system aims to enhance the bioavailability and delivery of EK-16A to various organs. The composition of EK-16A-SNEDDS was optimized through self-emulsifying grading and ternary phase diagram tests. Cell models, pharmacokinetic experiments, and pharmacodynamics in HIV-1 latent cell transplant animal models suggested that EK-16A-SNEDDS could be absorbed by the gastrointestinal tract and enter the blood circulation after oral administration, thereby reaching various organs to activate latent HIV-1. The prepared EK-16A-SNEDDS demonstrated safety and efficacy, exhibited high clinical experimental potential, and may be a promising oral preparation for eliminating HIV-1 latent reservoirs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Virus LatencyEmulsionsAnimalsAdministration, OralHumansVirus ActivationEuphorbiaHIV InfectionsPlant ExtractsBiological AvailabilityNanoparticle Drug Delivery SystemAnti-HIV AgentsMaleDrug Delivery SystemsMice

Stichwörter der Autor:innen

EK-16AHIV latent reservoirHIV-1LRAOral formulationSNEDDS

Substanzen

EmulsionsPlant ExtractsNanoparticle Drug Delivery SystemAnti-HIV Agents

Autor:innen und Institutionen

  • State Key Laboratory of Genetic Engineering and Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200438, China; Key…
  • State Key Laboratory of Genetic Engineering and Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200438, China.
  • State Key Laboratory of Genetic Engineering and Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200438, China; Yiw…
  • State Key Laboratory of Genetic Engineering and Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200438, China. Ele…
  • Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China. Electronic address: qijianping@fudan.edu.cn.

Zitieren

APA

Yang, J., Shi, C., Cheng, Y., Zhu, Y., Yang, X., Liang, Y., Liang, H., Lin, Q., Li, M., Xun, J., Liu, J., Yin, C., Qi, J., & Zhu, H. (2024). Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114353

Vancouver

Yang J, Shi C, Cheng Y, Zhu Y, Yang X, Liang Y, et al. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114353

BibTeX
@article{Yang2024,
  author = {Yang, Jinlong and Shi, Chenyi and Cheng, Yipeng and Zhu, Yuqi and Yang, Xinyi and Liang, Yue and Liang, Huitong and Lin, Qinru and Li, Min and Xun, Jingna and Liu, Jianping and Yin, Chunhua and Qi, Jianping and Zhu, Huanzhang},
  title = {Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2024},
  doi = {10.1016/j.ejpb.2024.114353}
}
Kostenlos starten →